Sanara Medtech (SMTI) Osake Kurssi
Sanara Medtech Kurssi
Liikevaihto on kasvanut 39,3 % vuodessa viimeisten 19 vuoden aikana 103,12 M USD:een. Sanara Medtechn nettomarginaali on nyt −36,4 %, laskenut −32,8 %:sta muutama vuosi sitten. Analyytikoiden mediaanitavoitehinta on 35,00 USD, eli yli nykyhintaa 6,7 %. 8 analyytikosta 0 suosittaa ostoa — kokonaiskonsensus on Pidä.
Sanara Medtech osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Sanara Medtech liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Sanara Medtech -osakkeesta
The business model of Sanara Medtech Inc focuses on developing and commercializing innovative biotechnology and medical device products. The company aims to provide advanced wound care solutions to cater to the growing needs of patients worldwide. Sanara Medtech Inc leverages its expertise in wound healing and tissue regeneration to develop cutting-edge products that enhance patient outcomes. By offering a diverse portfolio of advanced products, the company aims to address the unmet needs of healthcare professionals and improve the quality of life for patients. Sanara Medtech Inc continually strives to expand its market presence and deliver innovative solutions for wound healing and tissue repair.
Sanara Medtech Inc is primarily active in the medical technology industry.
The main competitors of Sanara Medtech Inc in the market include companies such as Acelity, Mölnlycke Health Care, and Smith & Nephew.
Sanara Medtech Inc, formerly known as Wound Management Technologies, is a Texas-based medical technology company. It specializes in developing and commercializing advanced wound care products. Established in 2014, Sanara Medtech focuses on delivering innovative solutions to address acute and chronic wounds. Their products include a range of advanced wound dressings, collagen-based dressings, and therapeutic lotions designed to promote healing and improve patient outcomes. With a dedicated team of experts and strong research and development capabilities, Sanara Medtech is committed to providing effective and reliable wound care solutions to patients and healthcare providers worldwide.
Sanara Medtech Inc has achieved several significant milestones. The company successfully developed and commercialized its flagship product, the BIAKŌS® Antimicrobial Barrier Film, which provides advanced wound care solutions. Sanara Medtech Inc also received FDA 510(k) clearance for its BIAKŌS® Wound Gel, expanding its product portfolio. Additionally, the company formed strategic partnerships with healthcare providers and established distribution agreements to enhance market reach. Sanara Medtech Inc's dedication to innovation, regulatory compliance, and customer satisfaction has solidified its position as a leader in the medical technology industry.
Sanara Medtech Inc is primarily present in the United States.
Sanara Medtech Inc is a reputable company known for its strong values and corporate philosophy. With a customer-centric approach, they prioritize innovation, excellence, and integrity in all their operations. Sanara Medtech Inc aims to provide cutting-edge medical technologies and solutions that improve patient outcomes and quality of life. Backed by a highly skilled team and state-of-the-art research, they strive to deliver superior healthcare products and services. By fostering partnerships and collaboration, Sanara Medtech Inc demonstrates a commitment to advancing medical advancements and driving positive change in the industry. Their dedication to promoting excellence and integrity sets them apart as a leader in the healthcare sector.
Analyytikot asettavat tällä hetkellä Sanara Medtech-osakkeelle keskimääräisen tavoitehinnan 35,00 USD (mediaani: 35,00 USD), mikä merkitsee +6,7 % viimeisimpään hintaan verrattuna. Konsensus perustuu 8 analyytikkoarvioon.
8 analyytikkoa arvioi tällä hetkellä Sanara Medtech-osaketta: 0 suosittaa ostoa, 5 pitoa ja 3 myyntiä. Vuodelle 2026 analyytikot odottavat Sanara Medtech-yhtiöltä 116,83 M USD liikevaihtoa ja 0,20 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Sanara Medtech-osake noteerataan hintaan 29,32 EUR (32,80 USD).
Sanara Medtech-osake (SMTI) on listattuna 1 pörssissä, muun muassa: NASDAQ (SMTI).
Sanara Medtech Inc. is a leading company in the field of wound care and offers innovative products and solutions for wound healing. The company is headquartered in Dallas, Texas and was founded in 2014. It specializes in providing patients and medical professionals with new products and technologies with clinically proven results. Sanara Medtech operates in three main areas: wound healing, incontinence and hygiene products, and hernia care. In the field of wound healing, the company offers a range of products specifically designed to accelerate and improve wound healing. This is achieved through the use of innovative dressing systems that regulate moisture, temperature, and oxygen levels to achieve optimal healing outcomes. In the incontinence and hygiene products sector, Sanara Medtech provides bladder and bowel incontinence management. Special absorbent pads and underpads are provided that are suitable for both men and women. The company also offers effective and skin-friendly cleansing lotions and cleaning products. In the hernia care sector, the company offers various implants and meshes. These include both new developments and standard products used for the stabilization of abdominal wall hernias. The products are surgical instruments and medical devices manufactured to the highest quality standards to achieve the best possible benefit for patients. Sanara Medtech's business model is focused on the healthcare market and aims to provide the best customer service and products in the field of wound care and medical devices. To achieve this, the company works closely with medical professionals and patient organizations. Sanara Medtech is committed to continuously improving existing products and offering innovative solutions in wound care to provide the best possible benefit for patients. Innovation, quality, and customer service are the key elements of Sanara Medtech's business model. The company relies on effective organization and coordination of all business areas, from research and development to sales. Sanara Medtech also aims to ensure sustainable economic growth through appropriate measures. In summary, Sanara Medtech Inc. is a company operating in the fields of wound healing, incontinence and hygiene products, and hernia care. The company offers innovative products and solutions of the highest quality standard and is committed to achieving the best possible benefit for patients through continuous research and development. The close partnerships with medical professionals and patient organizations enable the company to develop innovative products and provide the best possible customer service.
odotettu liikevaihto Sanara Medtech on 116,83 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Sanara Medtech on 1,70 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Sanara Medtech:n hinta-voitto-suhde (P/E) on tällä hetkellä 166,51. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Sanara Medtech-osakkeen arvostusta.
Sanara Medtech:n hinta-myynti-suhde (P/S) on tällä hetkellä 2,42. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Sanara Medtech-osakkeen arvostuskennuslukuna.
Sanara Medtech:n Eulpool-laatuscore on 5/10.
Sanara Medtech:n ISIN on US79957L1008. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Sanara Medtech:n ticker on SMTI. Tämä pörssinoteeraus käytetään Sanara Medtech-osakkeiden kauppaan pörssissä.
Sanara Medtech osake
Sanara Medtech vertaisryhmä
Sanara Medtech Ticker
Sanara Medtech FIGI
Kaikki tunnusluvut ja syvällinen analyysi Sanara Medtech:sta
Meidän osakeanalyysimme Sanara Medtech-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Sanara Medtech:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: